Introduction

History & Background:
While several natural substances such as histamine, 5-Hydroxy tryptamine & bradykinine have the capacity to stimulate the smooth muscle of the uterus, only a few agents have been sufficiently evaluated for their safe use as oxytocic agents. These Includes oxytocin, some prostaglandin's (PG) and ergot alkaloids. In several areas of Obstetrics and Gynecology, prostaglandins and their analogues have established clinical applications 1 .
The first recorded biological effects of prostaglandins were by Kurzok and Lieb in 1930 when they observed the expulsion of human semen that have been introduced into the uterine cavity 2 . A few years later, the smooth muscle stimulating and blood pressure lowering activity of extracts of human seminal fluid was established independently by Gold blatt (1934, 1935) and von Euler (1934 Euler ( , 1935 . Believing that the active principle originated in the prostate, von Euler coined the name prostaglandin 3, 4, 5, 6 . Eliasson (1959) showed that the seminal prostaglandins originate Several studies have evaluated misoprostol for use in interrupting first and second-trimester pregnancies [21] [22] [23] [24] [25] [26] [27] [28] . Compared with other prostaglandin preparations misoprostol is equally effective, cheaper, and easier to use [21] [22] [23] [24] .
A comparative study of oral & vaginal misoprostol for induction of labor at term was done by Nawarat from October 2001 to May 2003 in the department of Obstetrics & Gynaecology & division of Obstetrics & Gynaecology, Mahido University, Bangkok, Thailand. This study includes 153 pregnant women at term and Bishop score ≤ 6 were randomly assigned to receive misoprostol either 100mg orally or 50mg vaginally every 6 hours for 48 hours. Repeated dose was given until Bishop score ≥ 8 was achieved or spontaneous rupture of membrane occurred. Those who were not in labor after 48 hours, labour induced with amniotomy and oxytocin. The main out come measure was induction to delivery time. It was stated that the median induction to vaginal delivery time in oral group (14.3 h) was not significantly different form those of the vaginal group (15.8 h). There was a significant higher incidence of uterine tachysystole in the vaginal group compared to oral group (17.1% vs 5.3, P = 0.032). There was no hyper stimulation in either group & no significant differences with respect to oxytocin augmentation, cesarean section rate, analgesic requirement and neonatal outcomes. This study showed that oral 100mg misoprostol has similar efficacy to intravaginal 50mg misoprostol for labor induction with less frequent abnormal uterine contractility. So 100mg of misoprostol orally can be used as an alternative to the vaginal route for labor induction 29 .
Various regimens of oral & vaginal route are studied, such as 50mg every 4 hours orally and 6 hours orally 100-200mg every 3 hours, orally and 100mg vaginally followed by 100mg orally 2 hourly. All these studies show that vaginal route is more effective than oral route in terms of interval from induction to delivery. But uterine hyperstimulation and abnormal fetal heart rate pattern occurred more commonly in the vaginal route. So oral misoprostol is safer and better accepted by pregnant women 30, 31, 32, 33 .
Another comparative study was done by Saipin Pongsatha at department of Obstetrics & Gynaecology, Faculty of medicine Chiang University, Chiang Mai, Thailand to compare the efficacy & safety of 100mg oral misoprostol for induction of labor between the regimen of 3 hour and 6 hour internal administration. 100mg oral misoprostol 3 hourly is more effective than 6 hourly but there was no difference in mode of delivery, analgesic requirement, maternal complications and neonatal out come. A dose of 100mg misoprostol orally 3 hourly seems to be optimum regimen and the new option for labor induction 34 .
A comparative study of oral and vaginal misoprostol for uterus. Oxytocic effect caused by a change in myometrial cell membrane permeability to calcium ion leading to alteration in cell membrane -bound calcium ion.
Smooth muscle contraction
Collagenolysis-Ripening of cervix
Side effect of natural PG: PGE 1 and PGE 2 have similar side effect and risk profiles including uterine hyper tonicity, fetal heart rate deceleration, fetal distress, nausea, vomiting, fever, and peripartum infection. 13 
Synthetic Analogues:
During last two decades a lot of studies have been done. PGE 2 & PGE 1 analogues show high success rates and lower side effect than natural PG 1 .
Contraindication of prostaglandin:
Absolute: PGE analogue should not be used in patients with a history of Asthma, glaucoma or myocardial infraction.
Relative: unexplained vaginal bleeding, chorioamnionitis, ruptured membranes or previous cesarean section are all relative contraindications the use of prostaglandins for cervical ripening 13 .
Therapeutic use:
The successful first time use of natural prostaglandins for induction of labour at term (Karim 1968; Karim 1970) 46 .
A double blind placebo controlled randomized trial of oral misoprostol (400µg) and oxytocin 10.u. I/M in the management of the third stage of labor showed that in low risk women oral misoprostol appears to be as effective in minimizing blood loss in the third stage of labor as intramuscular oxytocin. Shivering was noted more frequently with misoprostol use, but no other side effects were noted. Misoprostol has great Potential for use in the third stage of labor especially in developing Countries 47 .
Postpartum hemorrhage is an important cause of maternal mortality and morbidity. In the developing world, it is estimated to account for 28% of maternal deaths. Evidence suggests that active management of the third stage of labor using Oxytocics, significantly reduces the risk of PPH. Oxytocics are not always used in the developing world, due induction of labour at term was done by Janice at Kingerten General Hospital, Ontario, Canada. Including 167 patients from July 1997 to May 1998 showed that vaginal misoprostol compared with oral misoprostol, vaginal misoprostol for induction of labour at term results in a shorter induction-to-delivery time, with fewer doses required per patient. Vaginal misoprostol may be associated with higher rates of caesarean section than oral misoprostol 35 .
Misoprostol is administered orally and effective in inducing of abortion in both the 1st and 2nd trimester of pregnancy and are also used to promote the expulsion of a missed abortion 36 .
A comparative study out come of 2nd trimester pregnancy terminations with misoprostol was done by Rodney and Shireen at Shands Hospital at the university of Florida form June 1996 to February 2004 on 147 women undergoing medical termination of pregnancy at 13 to 27 weeks. For low dose 200mg intravaginally 12 hourly (h=100) and high dose intravaginal 400µg every 6 hour (h 47) group respectively, median times to delivery were 22.5 VS 13.25 hours (p .001).
More patients in the high dose group were delivered vaginally within 24 (81% VS 54%; P = .002) and 48 hours (98% VS 27%; P = .014). Clinical chorioamnitis was more common on high dose group (p = .03). Side effects were uncommon in both groups. One patient experience of uterine rupture & include in the analysis, this study shows that high dose (400µg every 6 hour) regimen for termination of pregnancy effects delivery more rapidly without an appreciable increase in side effects or complications 37 .
Another study showed that women carrying dead fetus deliver more rapidly when undergoing medical termination of pregnancy in 2nd trimester 27, 28 .
A prospective study on 63 pregnant women (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) 27. Srisomboon J, pongpisuttinum S. Efficacy of intracervicovaginal misoprostol in second frimester pregnancy termination: a comparison between live and to storage problems, mode of administration and associated side-effects. Research using misoprostol, a prostaglandin, suggests that it may be effective in the prevention of PPH. It is given orally, does not require refrigeration and has few side-effects further research is planned, if misoprostol is found to be acceptable alternative to other oxytocic agents, and then it may be instrumental in reducing world wide death from PPH 48 .
Misoprostol has been the drug of choice for induction of labor & cervical priming in developing countries during almost a decade, because it is cheap, stable at room temperatures, does not require refrigeration prior to use, easy to prepare and the route of administration is convenient. It is used in 3rd stage of labour for the prevention of postpartum Hemorrhage. It is also a common drug for termination of early pregnancy and expulsion of missed abortion.
